OrthoApnea S.L. v. Vivisol B BV

UPC_CFI_131/2025

This UPC decision concerns a request for costs determination in the context of an ongoing infringement case. The court suspended the cost procedure because the defendant had filed an appeal against the initial ruling. This highlights the principle that final cost allocation must wait until the main dispute is definitively resolved by the appellate body, ensuring legal certainty and preventing fragmented judgments.

Jurisdiction
European UPC
Court
Brussels (BE) Local Division
Case Number
UPC_CFI_131/2025
Decision Date
2 May 2025

What the Court Held — Ratio Decidendi

The court ruled to suspend the cost determination proceedings because the defendant had lodged an appeal against the initial decision. The court emphasized that, in line with UPC jurisprudence and legal certainty, costs compensation cannot be fragmented across different stages of litigation; it must await the final judgment on the merits.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Brussels (BE) Local Division. Understanding the court's reasoning in OrthoApnea S.L. vs Vivisol B BV is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentApp_47098/2024

Netgear Inc.vsHuawei Technologies Co. Ltd.

This procedural order in the UPC case UPC_CFI_152/2024 involves Netgear (claimant) and Huawei (respondent). The court addressed two key procedural matters: incorporating a relevant Qualcomm license agreement from a prior infringement case into the current non-infringement determination, and assigning an expert judge. The decision emphasizes judicial efficiency by linking proceedings and utilizing specialized expertise to handle complex cross-case issues.

patentApp_1202/2025

Motorola Mobility LLCvsTelefonaktiebolaget LM Ericsson

This procedural order in the UPC addressed a request by Ericsson (Defendants) to classify certain information related to pre-dispute license negotiations as confidential under R. 262A RoP. Ericsson sought protection for internal calculations and negotiation details, arguing they were highly confidential business secrets. The Court ultimately rejected this application entirely, emphasizing that parties cannot restrict their own access to their proprietary information during proceedings.

patentApp_68465/2024

Abbott Diabetes Care Inc.vsDexcom Inc.

In a procedural ruling, the UPC Court of First Instance allowed the withdrawal of all claims in the case involving Abbott Diabetes Care Inc. and Dexcom Inc. Both parties mutually consented to drop their infringement claim and counterclaims for revocation regarding EP4070727. The court formally closed the proceedings, noting that no cost decision was required.

patentORD_7587/2024

Panasonic Holdings CorporationvsOROPE Germany GmbH, Guangdong OPPO Mobile Telecommunications Corp. Ltd.

In a procedural ruling, the Mannheim Local Division addressed the complex interplay between infringement and invalidity claims in UPC case UPC_CFI_216/2023. The court decided to consolidate the proceedings, meaning that Panasonic's infringement claim will be heard alongside OROPE and OPPO's counterclaim for patent invalidity and FRAND licensing. This consolidation aims to ensure a unified legal interpretation across all issues, streamlining the litigation process.

patentORD_48922/2024

Volkswagen AGvsNetwork System Technologies LLC.

In this appeal concerning security for costs, the UPC Court of Appeal addressed the financial vulnerability of a patent enforcement entity (NST) versus a large corporate defendant (Volkswagen). The court ruled that while the relative size of the parties is not a determining factor, the requesting party must provide concrete evidence of an actual risk of non-recoverability or unenforceability. Consequently, the previous order was set aside, and NST was ordered to post security for costs in specific amounts.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call